Marburg Virus Disease (MVD)
Explore this page for Marburg Virus Disease information, resources, and news.
About Marburg Virus Disease (MVD)
According to the National Emerging Special Pathogens Training and Education Center (NETEC), Marburg virus disease (MVD) is a rare yet severe illness caused by the Marburg virus, which belongs to the same viral family (filovirus) as Ebola. The Centers for Disease Control and Prevention (CDC) reports that the majority of MVD outbreaks have occurred in Sub-Saharan Africa; however, the virus can spread globally through infected travelers or accidental laboratory infections.
Currently, there are no Food and Drug Administration (FDA)-approved vaccines or treatments for MVD. In the absence of early diagnosis and appropriate supportive care, the mortality rate for MVD ranges from 23% to 90%. With prompt intensive supportive care and fluid replacement, it is possible to achieve lower mortality rates.
Explore
Tanzania 2025
- Jan. 22, 2025: NETEC: Situation Report
- Jan. 20, 2025 | Tanzania Declares Marburg Outbreak: Africa CDC Mobilizes Immediate Response | Africa CDC
- Jan. 15, 2025 | Possible Marburg Outbreak in the United Republic of Tanzania: Current Situation | CDC
Rwanda 2024
-
Jan. 22, 2025 | Marburg Virus Disease in Rwanda — Centering Both Evidence and Equity
- According to the WHO, the Marburg outbreak in Rwanda was declared over on December 20, 2024.
Equatorial Guinea & Tanzania 2023
- Equatorial Guinea and Tanzania delcared the end of the Marburg outbreak in May and June 2023, respectively.
The GCHS, in collaboration with the Region VII Disaster Health Response Ecosystem (R7DHRE) conducts biweekly meetings with local and state public health and healthcare representatives. These meetings focus on reviewing and discussing recent developments related to current infectious disease challenges. Dr. James V. Lawler, MD, MPH, FIDSA, presents comprehensive updates on data and advancements at local, state, national, and international levels. Additionally, regional experts offer insights into current outbreaks and clinical situations within Region 7. Register here.